Attention AACR-NCI-EORTC Molecular Targets Conference Registrants - Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Molecular Response Prediction Markers (Plenary Session)

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Molecular Markers Predictive of Response to EGFR Inhibitors
Bruce E. Johnson, M.D.
Dana-Farber Cancer Institute, Boston, MA
from 2008 Molecular Diagnostics in Cancer Therapeutic Development conference on September 24, 2008 8:00 AM-10:15 AM
Genomic Strategies towards Personalized Cancer Therapy
Joseph R. Nevins, Ph.D.
Duke University, Durham, NC
from 2008 Molecular Diagnostics in Cancer Therapeutic Development conference on September 24, 2008 8:00 AM-10:15 AM
Targeting the Hedgehog Pathway: From Bench to Clinic
Frederic de Sauvage, Ph.D.
Genentech, Inc., San Francisco, CA
from 2008 Molecular Diagnostics in Cancer Therapeutic Development conference on September 24, 2008 8:00 AM-10:15 AM
An Intermediate Methlyation Signature is Associated with Improved Patient Survival and a Distinct Global mRNA Expression Profile in Glioblastoma: An Interim Analysis of The Cancer Genome Atlas Data
Christopher E. Pelloski, M.D.
UT M. D. Anderson Cancer Center, Houston, TX
from 2008 Molecular Diagnostics in Cancer Therapeutic Development conference on September 24, 2008 8:00 AM-10:15 AM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4